Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Compass Therapeutics (CMPX) Return on Assets (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Return on Assets for 3 consecutive years, with 0.32% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 5.0% to 0.32% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.32% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.4% for FY2025, 2.0% down from the prior year.
  • Return on Assets hit 0.32% in Q4 2025 for Compass Therapeutics, up from 0.4% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.26% in Q4 2023 to a low of 0.54% in Q2 2025.
  • Historically, Return on Assets has averaged 0.36% across 3 years, with a median of 0.32% in 2024.
  • Biggest YoY gain for Return on Assets was 5bps in 2025; the steepest drop was -24bps in 2025.
  • Year by year, Return on Assets stood at 0.26% in 2023, then plummeted by -40bps to 0.36% in 2024, then increased by 13bps to 0.32% in 2025.
  • Business Quant data shows Return on Assets for CMPX at 0.32% in Q4 2025, 0.4% in Q3 2025, and 0.54% in Q2 2025.